# Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes

> **NCT06120556** · — · COMPLETED · sponsor: **Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari** · enrollment: 130 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** GLP-1 receptor agonist

## Key facts

- **NCT ID:** NCT06120556
- **Lead sponsor:** Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-10
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2024-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06120556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06120556, "Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06120556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*